• Profile
Close

Severe infections in systemic lupus erythematosus: Disease pattern and predictors of infection-related mortality

Clinical Rheumatology Apr 23, 2018

Teh CL, et al. - Authors ascertained the pattern of serious infections in patients with systemic lupus erythematosus (SLE). They also identified the predictors of infection-related mortality among these patients with serious infections. The predominant pattern of infection in this SLE cohort were pneumonia and Gram-negative organisms. The independent prognostic predictors of infection-related mortality were the presence of flare of SLE and bacteremia, whereas, among SLE patients with serious infections, hydroxychloroquine was protective of infection-related mortality.

Methods

  • Experts prospectively studied all SLE patients who were hospitalized with infections in Sarawak General Hospital during 2011–2015.
  • They collected the demographic data, clinical features, and outcomes.
  • To determine the independent predictors of infection-related mortality, Cox regression analysis was carried out .

Results

  • As per data, there were a total of 125 patients with 187 episodes of serious infections.
  • Findings suggested the patients to be of multiethnic origins with female predominance (89.6%).
  • The mean age was noted to be 33.4 ± 14.2 years.
  • The mean disease duration in patients was 66.8 ± 74.0 months.
  • Pulmonary (37.9%) was the most common site of infection, followed by septicemia (22.5%).
  • Within the cohort, gram-negative organisms (38.2%) were the predominant isolates.
  • Researchers noted 21 deaths (11.2%) during the study period.
  • Flare of SLE (HR 3.98, CI 1.30–12.21) and the presence of bacteremia (HR 2.54, CI 0.98–6.59) were the independent predictors of infection-related mortality among this cohort of SLE patients.
  • The protective of mortality from serious infections (HR 9.26, CI 3.40–25.64) was hydroxychloroquine.
  • Results demonstrated that the pneumonia and Gram-negative organisms were the predominant pattern of infection in this SLE cohort.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay